Dr. Singhi speaks with us about the importance of biomarker testing and what you need to know to get the best lung cancer ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

Payer perspective regarding decisions for covering the costs of molecular assays in oncology and reimbursing oncologists for treatments provided to patients while navigating long turnaround times ...

Cost-Utility Analysis of Primary Prophylaxis Versus Secondary Prophylaxis With Granulocyte Colony-Stimulating Factor in Elderly Patients With Diffuse Aggressive Lymphoma Receiving Curative-Intent ...

In an ideal world, the oncologist meeting a patient newly diagnosed with nonsmall-cell lung cancer (NSCLC) will already have information on genetic mutations in the tumor, so can initiate targeted ...

The purpose of the study was to determine the screening performance of prenatal reflex DNA screening for trisomies 21 (T21), 18 (T18), and 13 (T13) as part of a routine service at five hospitals.

Molecular testing prior to first-line therapy in patients with stage IV nonsquamous non-small cell lung cancer (NSCLC): A survey of U.S. medical oncologists. This is an ASCO Meeting Abstract from the ...

A new device called the Blink Reflexometer™ could drastically improve field-side diagnostic capabilities used by athletic trainers and medical staff in diagnosing athletes suspected of having a ...

A new device called the Blink Reflexometer™ could drastically improve field-side diagnostic capabilities used by athletic trainers and medical staff in diagnosing athletes suspected of having a ...